Shorts are at the level of a year ago, then came citron and made everyone nervous. Now, we get the breakout we missed last year, I think. There is simply no short story anymore. Last year we broke out above 55 with much lower revenue/earnings. The company is much stronger now. More sales people, more inications are running hot, aquisitions. And not to forget Q2 will be great. If we get another "article attack" just after earnings, I think, all will just laugh and buy more.
With 17.6 million shorted shares and today's 0.268 million real trading shares, the days to cover those shorted shares are 65 trading days. There is no way for the shorted to escape but squeeze. The second Q's script number is 13 weekX300 = 3900 scripts. The average vial number is 2-4 vial per script, the shiped vial number for Q2 is between 7800 to 15600. Remember, The vial shipped during Q1 was 4830. The paid scrips was 1800.